Kabrita: Tested & Proven to Be 99.99% A2 β-Casein

A2 You Can Trust

Not all goat milk formulas are necessarily the same. At Kabrita, our A2 β-casein profile is not simply assumed based on the natural characteristics of goat milk.

Kabrita has been tested and proven to contain 99.99% A2 β-casein, providing parents with greater confidence in the protein they choose for their little ones.

With 99.99% A2 β-casein, Kabrita offers a predominantly A2 protein profile—an important consideration for parents looking for nutrition designed with digestive comfort in mind.

More Than A2: Naturally Gentle Goat Milk

Kabrita is made with high-quality goat milk from the Netherlands. Beyond its A2 β-casein profile, goat milk has natural characteristics that may support digestive comfort:

• Softer curd formation in the stomach (1): A softer and more fragile curd may be more readily broken down during digestion.
• Naturally smaller fat globules (2): Providing a greater surface area for digestive enzymes to act upon.
• Thoughtfully formulated for digestive wellbeing: Enhanced with probiotic BB-12(3),4),5), 2’-FL Human Milk Oligosaccharide (HMO)(6),(7), β-palmitate(8),(9).

A Gentle Choice from the Start

Good nutrition is not only about responding when digestive discomfort occurs. Making an informed choice from the beginning can help support digestive wellbeing and feeding comfort throughout a child's early development.

Because every little one deserves a gentle start. Choose the best you can give. Choose A2 milk.

References

1. Roy D, Moughan PJ, Ye A, Hodgkinson SM, Stroebinger N, Li S, et al. Structural changes in milk from different species during gastric digestion in piglets. Journal of Dairy Science [Internet]. 2022 Feb 25;105(5):3810–31. Available from: https://doi.org/10.3168/jds.2021-21388
2. Pisanu S, Marogna G, Pagnozzi D, Piccinini M, Leo G, Tanca A, et al. Characterization of size and composition of milk fat globules from Sarda and Saanen dairy goats. Small Ruminant Research [Internet]. 2012 Aug 25;109(2–3):141–51. Available from: https://doi.org/10.1016/j.smallrumres.2012.07.024
3. Chen K, Zhang G, Xie H, You L, Li H, Zhang Y, et al. Efficacy of Bifidobacterium animalis subsp. lactis, BB-12® on infant colic – a randomised, double-blinded, placebo-controlled study. Beneficial Microbes [Internet]. 2021 Sep 22;12(6):531–40. Available from: https://doi.org/10.3920/bm2020.0233
4. Schmidt RM, Laursen RP, Bruun S, Larnkjær A, Mølgaard C, Michaelsen KF, et al. Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial. Pediatric Allergy and Immunology [Internet]. 2019 Feb 21;30(3):335–40. Available from: https://doi.org/10.1111/pai.13018
5. Taipale TJ, Pienihäkkinen K, Isolauri E, Jokela JT, Söderling EM. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research [Internet]. 2015 Sep 15;79(1):65–9. Available from: https://doi.org/10.1038/pr.2015.174
6. Taipale TJ, Pienihäkkinen K, Isolauri E, Jokela JT, Söderling EM. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research [Internet]. 2015 Sep 15;79(1):65–9. Available from: https://doi.org/10.1038/pr.2015.174
7. Taipale TJ, Pienihäkkinen K, Isolauri E, Jokela JT, Söderling EM. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research [Internet]. 2015 Sep 15;79(1):65–9. Available from: https://doi.org/10.1038/pr.2015.174
8. Taipale TJ, Pienihäkkinen K, Isolauri E, Jokela JT, Söderling EM. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatric Research [Internet]. 2015 Sep 15;79(1):65–9. Available from: https://doi.org/10.1038/pr.2015.174
9. Bronsky J, Campoy C, Embleton N, Fewtrell M, Mis NF, Gerasimidis K, et al. Palm oil and beta‐palmitate in infant formula. Journal of Pediatric Gastroenterology and Nutrition [Internet]. 2019 Feb 21;68(5):742–60. https://doi.org/10.1097/mpg.0000000000002307